Promoted Content
Promoted Content

Overview of Triptorelin

Client Email Product
Triptorelin
  • Synopsis

  • Chemistry

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

API Market Place

INTERMEDIATES

0

DOSSIERS
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

Dossiers Market Place

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

MEDIA

Blog

News

REFERENCE STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

SERVICES

0

  • WHO-GMP
Applications: Orally Disintegrating Tablets,Sachets, Dispersible Tablets, Sachets, Chewable Tablets, Sublingual Tablets
Ingredient(s): Crospovidone
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to Japanese Pharmaceutical Excipients. All components meet USP-NF, JP, EP. US DMF Type IV filed.
Technical Specifications: Not Available
  • WHO-GMP
Applications: Orally Disintegrating Tablets (ODTs), Sachets, Dispersible Tablets, Sachets, Chewable Tablets, Sublingual Tablets.
Ingredient(s): Crospovidone
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to Japanese Pharmaceutical Excipients. All components meet USP-NF, JP and EP.
Technical Specifications: Not Available
  • WHO-GMP
Applications: Direct Compression for pH sensitive APIs
Ingredient(s): Crospovidone
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Mannitol, Light Magnesium Oxide, Hydroxy Propyl Cellulose and Crospovidone
    Applications: It is used as a disintegrating agent.
    Dosage Form: Capsule, Tablet
    More Info on Category: Disintegrants & Superdisintegrants
    Route of Administration (Grade): Not Available
    Pharmacopoeia Reference: Not Available
    Technical Specifications: Also Available as Disolcel® GF
      Applications: HiCel HFE has various advantages such as Improved flow, Superior compactibility, low sensitivity to lubrication, better disintegration properties. It is used in direct compression of chewable tablets, fast dissolving tablets & mouth feel enhancement.
      Ingredient(s): Mannitol
      Route of Administration (Grade): Oral
      Pharmacopoeia Reference: Not Available
      Technical Specifications: Not Available
      left grey arrow
      right gray arrow
      • INJECTABLE;INTRAMUSCULAR - EQ 3.75MG BASE/VIAL
      • FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - EQ 22.5MG BASE/VIAL
      • INJECTABLE;INTRAMUSCULAR - EQ 11.25MG BASE/VIAL
      • INJECTABLE;INTRAMUSCULAR - EQ 22.5MG BASE/VIAL
      Ask Us for Pharmaceutical Supplier and Partner
      Ask Us, Find A Supplier / Partner
      No Commissions, No Strings Attached, Get Connected for FREE

      What are you looking for?

      How can we help you?

      The request can't be empty

      Please read our Privacy Policy carefully

      You must agree to the privacy policy

      The name can't be empty
      The company can't be empty.
      The email can't be empty Please enter a valid email.
      The mobile can't be empty